Indigo is a EC Horizon 2020 project in partnership with India’s Department of Biotechnology
Dr. Kang received her training in medicine and microbiology at the Christian Medical College (CMC), Vellore in southern India and is Professor of Microbiology at CMC. She works on enteric infections in children, particularly on transmission and immune responses, in order to design effective interventions. Current studies include vaccine preventable disease surveillance and clinical trials of new and existing vaccines. She has conducted phase I-IV vaccine trials in India. She was awarded the Infosys Prize in Life Sciences in 2016 for her contributions to understanding the natural history of rotavirus and other infectious diseases, She is on many review committees for national and international research funding agencies, and has served on several advisory committees mainly related to vaccines, including the WHO’s Global Advisory Committee on Vaccine Safety and the Immunisation and Vaccine Implementation Research Advisory Committee. She chairs the WHO SEAR’s Regional Immunisation Technical Advisory Group, is vice-Chair of the Board of the Coalition for Epidemic Preparedness Innovations and serves on India’s National Technical Advisory Group on Immunisation, the Influenza Vaccine Roadmap Task Force and the WHO Product Development Vaccine Advisory Committee. Dr. Kang will lead the INDIGO program team in India.